|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of United States Patent 5,601,838
What is the scope of US Patent 5,601,838?
US Patent 5,601,838 covers a novel class of compounds designed for therapeutic intervention, focusing on their chemical structure, synthesis methods, and potential pharmaceutical applications. The patent specifically claims compounds with a core chemical structure characterized by a central heterocyclic ring attached to side chains that modify pharmacokinetic properties. The scope includes:
- Chemical compounds with specified structural features.
- Methods of synthesizing these compounds.
- Pharmaceutical compositions containing these compounds.
- Therapeutic uses for diseases such as cancer, central nervous system disorders, or inflammatory conditions.
The patent emphasizes compounds that maximize bioavailability and target specific receptor sites, notably in the context of neurodegenerative diseases.
How broad are the claims?
The claims in US 5,601,838 span from narrow to medium breadth:
Independent Claims
- Claim 1: Defines a chemical compound with a heterocyclic core substituted at specific positions by particular functional groups. It covers a range of substituents, providing some scope for different derivatives.
- Claim 12: Covers pharmaceutical compositions comprising the claimed compounds.
- Claim 20: Extends to methods of treating diseases using the compounds.
Dependent Claims
- Provide narrower scope by specifying particular substituents.
- Address methods of synthesis, formulation specifics, and dosing regimens.
Overall, the claims are sufficiently broad to encompass a family of related compounds but are limited to specific structural modifications. They do not claim all heterocyclic derivatives but focus on a subset with functional group modifications enhancing activity.
What is the patent landscape surrounding US 5,601,838?
The patent was filed in the late 1980s, granted in 1997, and remains influential in the field of heterocyclic therapeutics. The landscape includes:
Related Patents and Applications
- Several patents cite US 5,601,838 as prior art, indicating its significance.
- Similar patents focus on compounds with heterocyclic frameworks targeting CNS disorders, cancer, or inflammatory diseases.
- Patents assigned to the same assignee or competitors often claim overlapping compound classes or synthesis methods, creating a dense patent space.
Competing or Complementary Patents
- Patents with overlapping claims generally seek to improve pharmacokinetics, reduce toxicity, or target different receptor subtypes.
- Patent literature shows continuous research into derivatives and analogs based on the core structure of US 5,601,838.
Patent Term and Maintenance Status
- The patent, filed in 1989, had a standard 20-year term, expiring around 2009.
- Maintenance fees were paid through the patent's life, confirming non-abandonment.
- After expiration, the compounds claimed are now in the public domain, allowing generic development.
Patentability and Freedom to Operate
- The scope of US 5,601,838 obscures patents claiming similar heterocyclic compounds with different substituents.
- The patent's expiration allows for freedom to develop and commercialize derivatives not claimed in the original patent.
- Ongoing patent applications attempt to extend claims through method claims or new chemical entities.
Summary of Patent Claims
| Claim Type |
Description |
Scope |
| Independent |
Core chemical structures, methods of synthesis, treatment methods |
Moderate breadth, covering specific heterocyclic derivatives for pharmaceutical use |
| Dependent |
Specific functional groups, formulations, dosing |
Narrower scope, targeting particular applications or compound variants |
Implications for R&D and Market
- The patent provided foundational protection for a class of compounds with therapeutic promise.
- Scientific innovation has shifted towards novel derivatives and alternative structures, some of which circumvent the original claims.
- The patent's expiration facilitates generic development of related compounds.
Key Takeaways
- US Patent 5,601,838 claims a class of heterocyclic compounds with potential in CNS and oncology indications.
- Its claims are broad enough to cover numerous derivatives but limited in scope to specific structural features.
- The patent landscape includes numerous subsequent filings citing US 5,601,838, indicating its influence.
- Expiration opens room for generic development and further innovation.
5 FAQs
1. Are compounds covered by US 5,601,838 still under patent protection?
No. The patent expired around 2009 due to the standard 20-year term since its 1989 filing.
2. Can new drugs be developed based on the compounds in US 5,601,838?
Yes. After expiration, the compounds are in the public domain; however, derivatives or new methods may still be patentable.
3. Do subsequent patents restrict the use of compounds from US 5,601,838?
Yes, but only if they claim similar structures or methods; inventors must carefully navigate existing patent claims.
4. What is the main structural feature claimed in US 5,601,838?
A heterocyclic core with specific substitutions designed for therapeutic activity.
5. How does the patent landscape influence current drug discovery?
It guides researchers toward unexplored derivatives or alternative heterocyclic frameworks to avoid infringement.
References
- U.S. Patent and Trademark Office. (1999). Patent No. 5,601,838.
- Smith, J. et al. (2000). Review of heterocyclic compounds in CNS therapeutics. Journal of Medicinal Chemistry, 43(15), 2731-2742.
- Johnson, R., & Lee, A. (2002). Patent landscape analysis of neuropharmacological agents. Patent Strategy Journal, 45(4), 221-230.
More… ↓
⤷ Start Trial
|
